Atossa Therapeutics, Inc. Receives Authorization from FDA to Initiate its Phase 2 Study of Neoadjuvant (Z)-endoxifen in Premenopausal Women with ER+/HER2- Breast Cancer
Stock Information for Atossa Therapeutics Inc.
Loading
Please wait while we load your information from QuoteMedia.